T1	Participants 400 414	Forty patients
T2	Participants 629 670	group 2 patients than in group 1 patients
T3	Participants 671 744	(mean+/-SD: 3.85+/-1.98 for group 1 vs. 2.78+/-1.03 for group 2, P=0.044)
